Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

OTCQX:MRVFF - Post Discussion

View:
Post by Marathon11 on Dec 08, 2020 5:14pm

What's Up?

Based on the Nuvo Shareholders' presentation on November 16 there was still an expectation to have both Resultz "Partner announced for U.S." and "Review decision from AGES" in Q4 2020. That sounds encouraging. Also, approx. 139K of a total of 143K shorts covered in late October... all good.
But then, based on the report I receive, it appears that a BOD member disposed of over 32K shares just after the Shareholders' presentation... can someone please confirm?
Also, short positions seem to be increasing... again, based on a dated report that only shows up until November 30.
Are we all getting the same info? What is happening? I believe, the Resultz patent in the US expires in 2024 (please correct me if I am wrong). How much has been lost because a deal wasn't cut earlier.
Appreciate someone telling me I am wrong. I hope I am.
All in my opinion.
Comment by lscfa on Dec 08, 2020 5:43pm
Date Issuer Insider Transaction Amount New Balance Filed 2020-11-20 13:28   Tx date 2020-11-20 $NRI  Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) Dobranowski, Anthony Edward 4 - Director of Issuer Direct Ownership Common Shares 10 - ...more  
Comment by lscfa on Dec 08, 2020 5:46pm
Short Positions   see all companies Symbol Issue Name Shares Net Change Date $NRI.TO NUVO PHARMACEUTICALS INC. 15,844 6,738 3 Dec 2020 $NRI.TO NUVO PHARMACEUTICALS INC. 9,106 5,403  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities